ANTIDIABETIC AND ANTIHYPERLIPIDEMIC ACTIVITY OF CHONEMORPHA FRAGRANS AND ERYTHROXYLUM MONOGYNUM COMBINED ETHANOLIC LEAF EXTRACT IN ALLOXAN INDUCED DIABETIC WISTAR RATS by Kausar Fatima*, Konde Abbulu
 www.iajpr.com 
 
P
ag
e7
4
2
8
 
                                               Indo American Journal of Pharmaceutical Research, 2017               ISSN NO: 2231-6876 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANTIDIABETIC AND ANTIHYPERLIPIDEMIC ACTIVITY OF CHONEMORPHA 
FRAGRANS AND ERYTHROXYLUM MONOGYNUM COMBINED ETHANOLIC LEAF 
EXTRACT IN ALLOXAN INDUCED DIABETIC WISTAR RATS 
 
Kausar Fatima
*
, Konde Abbulu
 
Department of Pharmacology, CMR College of Pharmacy, Medchal, Hyderabad, Telangana. 
 
Corresponding author  
Kausar Fatima  
Assistant Professor 
CMR College of Pharmacy 
kausarfatima116@gmail.com 
 
 
 
 
 
 
 
 
 
 
Copy right © 2017 This is an Open Access article distributed under the terms of the Indo American journal of Pharmaceutical 
Research, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
ARTICLE INFO  ABSTRACT 
Article history 
Received 24/12/2016 
Available online 
31/01/2017 
 
Keywords 
Chonemorpha Fragrans, 
Erythroxylum Monogynum, 
Diabetes Mellitus, 
Hyperlipidemia, 
Alloxan Monohydrate, 
Glibenclamide. 
 
 The objective of the present study was to evaluate the antidiabetic and antihyperlipidemic 
activity of herbal formulation containing Chonemorpha fragrans and Erythroxylum 
monogynum in alloxan induced diabetic rats.  Diabetes mellitus is a group of syndrome 
characterized by hyperglycemia, altered metabolism of lipids, carbohydrates and proteins and 
an increased risk of complications from vascular diseases. Hyperlipidemia constitutes a major 
etiopathological factor for atherosclerosis. The preliminary phytochemical screening shows 
the presence of alkaloids, glycosides, carbohydrates, flavonoids, tannins, saponins, sterols, 
phenols and proteins. The antidiabetic and antihyperlipidemic effect of combined herbal 
formulation was studied in alloxan (150mg/kg b.w., i.p.) induced diabetes in wistar rats for 
doses 200 mg/kg b.w. and 400 mg/kg b.w. (p.o.) daily for 21 days, and the effect was 
compared with oral dose of 5mg/kg, b.w. glibenclamide. The effect of ethanolic leaf extracts 
of Chonemorpha fragrans and Erythroxylum monogynum on blood glucose, serum lipid 
profile total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-
C), low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol 
(VLDL-C) were measured in the diabetic rats. Diabetes caused by alloxan treatment increases 
the level of glucose and biochemical parameters in blood sample but treatment with combined 
herbal formulation, protects from diabetes and significantly decreases the elevated blood 
glucose, LDL, VLDL levels, total cholesterol levels and total triglycerides levels &  increases 
the HDL levels. In conclusion the present study indicates that the combined ethanolic leaf 
extracts of plants Chonemorpha fragrans and Erythroxylum monogynum possesses significant 
antidiabetic, antihyperlipidemic activity in alloxan induced diabetic rats.  
Please cite this article in press as Kausar Fatima et al. Antidiabetic and Antihyperlipidemic Activity of Chonemorpha Fragrans 
and Erythroxylum Monogynum Combined Ethanolic Leaf Extract in Alloxan Induced Diabetic Wistar Rats. Indo American Journal 
of Pharmaceutical Research.2017:7(01). 
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ITRODUCTION 
Diabetes mellitus is a metabolic disorder characterized by hyperglycemia, abnormal lipid and protein metabolism along with 
specific long-term complications affecting the retina, kidney and nervous system 
[1]
. Hyperglycemia is an important factor in the 
development and progression of the complications of diabetes mellitus 
[2]
. The pathogenesis of diabetes mellitus is managed by insulin 
and oral administration of hypoglycemic drugs such as sulfonylureas and biguanides 
[3]
. Unfortunately, apart from having a number of 
side effects, none of the oral synthetic hypoglycemic agents has been successful in maintaining euglycaemia and controlling longterm 
microvascular and macrovascular complications 
[3-5]
. The toxicity of oral antidiabetic agents differs widely in clinical manifestations, 
severity and treatment 
[6]
. The use of herbal medicines for the treatment of diabetes mellitus has gained importance throughout the 
world. The World Health Organization also recommended and encouraged this practice especially in countries where access to the 
conventional treatment of diabetes is not adequate 
[7].
 There is an increased demand to use natural products with antidiabetic activity 
due to the side effects associated with the use of insulin and oral hypoglycemic agents 
[8, 9]
. The available literature showed that there 
are more than 400 plant species having hypoglycemic activity 
[10-12]
. Though some of these plants have great reputation in the 
indigenous system of medicine for their antidiabetic activities, many remain to be scientifically established. Hypercholesterolemia and 
hypertriglyceridemia are common complications of diabetes mellitus in addition to hyperglycemia 
[13-15]
. The frequency of 
hyperlipidemia in diabetes is indeed very high, depending on the type of diabetes and its degree of control 
[16]
.Despite the introduction 
of hypoglycemic agents from natural and synthetic sources, diabetes and its secondary complications continue to be a major medical 
problem. Many indigenous Indian medicinal plants have been found to be useful to successfully manage diabetes. One of the great 
advantages of medicinal plants is that these are readily available and have no side effects 
[17]
. World Health Organization (WHO) 
[18]
 
has suggested the evaluation of the potential of plants as effective therapeutic agents, especially in area which we lack safe modern 
drugs. 
Medicinal plants play important roles in the management of type II diabetes especially in resource limited countries. In India, 
herbal medicines including polyherbal therapy is widely practiced. The combination of various types of agents from different plant 
sources could have synergistic, potentiative, antagonistic pharmacological and therapeutic effects with minimum side effects 
[19]
.Chonemorpha fragrans belongs to family Apocynaceae. It is a medicinal herb used in the indigenous system of medicine. Roots 
are useful in vitiated conditions of vata and kapha, skin diseases, leprosy, scabies. Roots of this plant are useful in dyspepsia, colic, 
constipation hyperacidity, cardiac debility, diabetes, jaundice, cough, bronchitis and intermittent fevers. It is also used in the treatment 
of diarrhea, polyuria, boils, leprosy, eye diseases, vomiting and poisoning 
[20]
.The leaf juice intake purifies blood. The leaf paste is 
applied on the affected part to cure skin diseases 
[21]
.Plant possess skeletal muscle relaxant effect & also used as antispasmodic. Roots 
& leaves are mostly effective in stomach problems. Leaves are used in the form of churna or extract and in combination with the other 
plant materials in their formulation administered orally. VS Shende et al found that the alcoholic extract of roots of Chonemorpha 
fragrans significantly reduced the blood glucose levels 
[22]
. 
Erythroxylum monogynum belonging to family Erythroxylaceace is a medicinal herb. Leaves raw or cooked are eaten to a  
considerable extent in times of famine. They contain a bitter tonic principle which might serve to relieve the pangs of hunger. 
Biological activity of the plant is hypothermic & CNS active. Leaf is diaphoretic, stimulant, diuretic, stomachic. A decoction is used 
for malarial fever.Leaf juice given orally as a cooling beverage and also administered for treating jaundice. Leaves crushed with black 
pepper and the extract is given orally to kill the intestinal worms. Stem bark decoction is used to treat hiccups and given orally in 
morning time on empty stomach for 4 weeks to treat itches .Bark and wood are used as febrifuge. Infusion of the wood and bark is 
considered as stomachic, diaphoretic and diuretic. Oil from the seed is used to cure psoriasis, skin diseases. General stimulant other 
effects are related to the potentiation of responses of sympathetically innervated organs to catecholamines, and to sympathetic nerve 
stimulation causing tachycardia and mydriasis. It is used as ophthalmic anaesthetic. Fruits are consumed to cure indigestion. Paste of 
roots in warm water is used to cure cough and skin diseases. Methanolic extract of leaves showed hepatoprotective activity 
[23]
. 
Methanolic extracts of aerial parts of E.monogynum showed cytotoxic action against brine shrimps & antitumour activity against the 
tumors induced by Agrobacterium tumefaciens using carrot disc anti-tumour bioassay 
[24]
. E.monogynum also possesses antioxidant 
activity 
[25]. 
Phytochemical analysis & screening of antibacterial activity of the methanol and acetone leaf extracts of C.guianensis and 
E.monogynum was carried out against Escherchia coli, Klebsiela pneumoniae, Pseudomonas putida and Staphylococcus aureus & it 
was found to possess antibacterial activity 
[26]
. 
The objective of this research was to investigate the antidiabetic and antihyperlipidemic activity of ethanolic combined leaf 
extracts of Chonemorpha fragrans and Erythroxylum monogynum by estimation of blood glucose levels and plasma lipid profile such 
as total cholesterol, triglyceride, high density lipoprotein, very low density lipoprotein and low density lipoprotein in alloxan induced 
diabetic rats. 
 
MATERIALS & METHODS 
Plant material 
The leaves of Chonemorpha fragrans (Moon) Alston family Apocynaceae and Erythroxylum monogynum (Roxb) Hochr 
family Erythroxylaceae were collected from botanical gardens of Sri Venkateshwara University Tirupati. The species were 
taxonomically identified and authenticated by Dr. Madhava Chetty, Assistant professor of Botany, Department of Pharmacognosy, Sri 
Venkateshwara University, Tirupathi. 
 
Chemicals  
Alloxan monohydrate was obtained from Universal Chemical Corporation Abids, Hyderabad. Glibenclamide was obtained as 
gift sample from Aurobindo pharma. All the chemicals and reagents used for the present study were of analytical grade. 
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Preparation of extract: 
The leaves of C.fragrans (C.F) and E.monogynum (E.M) were shade dried in room temperature for about 10days and then 
powdered which were later extracted by cold maceration technique using ethanol as solvent for 7 days with intermittent shaking. The 
extracts were evaporated to dryness to get the extract.The extract thus obtained was subjected for evaluation of antidiabetic and 
antihyperlipidemic activity. The individual extracts of C.fragrans (C.F) and E.monogynum (E.M) prepared were mixed in equal 
proportions in normal saline for pharmacological experiments. 
 
Phytochemical evaluation: 
Preliminary phytochemical screening was performed as per the standard methods 
[27].
The ethanolic leaf extracts of C.fragrans 
and E.monogynum were screened for the presence of various phytochemicals by employing standard conventional protocols 
[28-30].
 
 
Animals: 
Healthy adult male wistar rats weighing 180-250gms each were used for the study. Animals were maintained under standard 
environmental conditions (22-28°C, 60-70% relative humidity, 12hr Light and Dark cycle) and fed with standard feed and water ad 
libitum. The experimental protocol was approved by the Institutional Animal Ethics Committee. All studies were performed in 
accordance with the guidelines for the care and use of laboratory animals, as adopted and promulgated by the Animal Care committee, 
CPCSEA (Committee for the purpose of control and supervision of experiments on animals) with clearance no: 
001/CEAD/SES/SWCP/14. 
 
Acute toxicity studies: 
Acute toxicity study was performed as per Organization for Economic Co-operation and development OECD-425 guidelines. 
It was observed that there was no gross evidence of any abnormalities up to 4hrs and no mortality was observed in animals up to the 
end of 48hrs at the maximum tested dose level of 2000mg/kg b.w. in rats. This was considered as Maximum Tolerated Dose (MTD) 
and thus, 1/10th of MTD i.e., 200mg/kg b.w. was taken as test dose and double the test dose i.e., 400mg/kg b.w. was also selected for 
the experimental studies. 
 
Induction of diabetes in rats: 
Male Wistar rats (180-250gm) were made diabetic by a single i.p injection of Alloxan monohydrate at a dose of 150mg/kg 
using normal saline as vehicle which was freshly prepared immediately before injection. Alloxan also causes changes in serum lipid 
profile. The rats were maintained on 5% glucose solution for next 24hrs to prevent hypoglycemia. The diabetic state was confirmed by 
the measurement of fasting blood glucose concentration  
3 days after the alloxan treatment using the blood samples drawn from tail vein .The rats with effective and permanent 
elevated blood glucose levels above 250mg/dl were considered to be diabetic and were used for the study. 
 
Experimental design: 
The diabetic and hyperlipidemic rats were divided into 5 groups, each containing 6animals.  
Group I-    Normal control rats received normal saline p.o.  
Group II -  Diabetic control rats received alloxan (150mg/kg) b.w i.p in normal saline p.o.  
Group III- Alloxan induced diabetic rats treated with combined ethanolic leaf extract of Chonemorpha fragrans (C.F) and 
Erythroxylum monogynum (E.M) at a dose of 200mg/kg b.w, p.o.                            
Group IV-Alloxan induced diabetic rats treated with combined ethanolic leaf extract formulation of Chonemorpha fragrans (C.F) and 
Erythroxylum monogynum (E.M) at a dose of 400mg/kg b.w, p.o.                            
Group V - Alloxan induced diabetic rats treated with glibenclamide at a dose of 5mg/kg b.w, p.o.  
The administrations of extracts were continued for 21days, once daily. Blood samples were collected through the tail vein on days 1, 
7, 14 and 21 days after drug administration and the blood glucose levels were estimated using Accu-check glucometer.  
 
Estimation of blood cholesterol: 
Serum lipid profile estimation at the end of 21 days, blood was collected from inferior vena cava, serum separated for 
determination of parameters like total cholesterol, HDL- cholesterol and triglycerides. VLDL cholesterol and LDL-cholesterol were 
calculated using the Friedewald's formula. VLDL = Triglycerides/5 LDL =Total cholesterol-(HDL-CH+VLDL-CH) 
 
Statistical analysis: 
Results were expressed as Mean ± SEM. Statistical analysis were performed with instat software using one way analysis of 
variance (ANOVA) followed by Dunnet’s t -test. P values less than *p<0.05, p**<0.01, p***<0.001 were considered to be statistically 
significant, when compared with control and standard group as applicable. 
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RESULTS AND DISCUSSION 
 
Table 1: Phytochemical analysis of ethanolic leaf extracts of Chonemorpha fragrans and Erythroxylum monogynum. 
 
Type of constituents Chonemorpha fragrans ethanolic 
leaf extract 
Erythroxylum monogynum 
ethanolic leaf extract 
Alkaloids + + 
Glycosides + + 
Carbohydrates + + 
Flavonoids + + 
Tannins _ + 
Saponins + + 
Sterols + + 
Phenols _ + 
Proteins + _ 
Triterpenoids _ _ 
Anthraquinones _ _ 
+ indicates presence and - indicates absence. 
 
Antidiabetic activity: 
The effect of Chonemopha fragrans (CF) and Erythroxylum monogynum (EM) on serum glucose levels in diabetic rats 
depicted in (Table 2). In animals treated with alloxan (150 mg/kg i.p) (Group II), a significant increase in serum glucose level was 
observed on 7th, 14
th
 & 21
st 
days when compared with normal rats (Group I). After the oral administration of ethanolic leaf extracts of 
Chonemorpha fragrans and Erythroxylum monogynum in diabetic control rats, a significant reduction in blood glucose level was 
observed on the 7th, 14
th
 and 21st compared with diabetic control rats. Group V received glibenclamide (5mg/kg p.o.) showed 
decrease in serum glucose level when compared with diabetic control rats (Group II). 
 
Table 2: Effect of ethanolic leaf extracts of Chonemorpha fragrans and Erythroxylum monogynum on blood glucose levels 
(mg/dl) in alloxan induced diabetic rats on 1
st
, 7th, 14
th
 and 21
st
 day of the treatment. 
 
Treatment Groups 1
st
 day 7
th
 day 14
th
 day 21
st
 day 
Normal control 97 ±0.83 97.8±1.31 96.5±1.62 96.3±1.65 
Diabetic control 257.7±2.37 266.±4.52 271.4±3.12 295.6±2.72 
CF & EM treated 
(200 mg/kg) 
 
249.4±2.06 
 
220.5±3.42 
 
195.2±2.52* 
 
172.4±3.25** 
CF & EM treated 
(400 mg/kg) 
 
245.6±2.45 
 
216.3±2.21* 
 
170.4±3.34** 
 
155.2±2.24** 
Glibenclamide treated (5mg/kg) 247.2±3.21 224.1±1.36** 159.4±1.65
** 
147.3±1.16** 
Values are expressed as Mean±SEM (n=6); *P<0.05, **P<0.01, ***P<0.001 was considered significant with respect to control group 
using ANOVA followed by Dunnett’s t-test. 
 
 
 
Figure 1: Blood glucose levels (mg/dl) on 1
st
, 7
th
, 14
th
 & 21
st
 day of treatment. 
 
Values are expressed as Mean±SEM (n=6); *P<0.05, **P<0.01, ***P<0.001 was considered significant with respect to control group 
using ANOVA followed by Dunnett’s t-test. 
                                                   
www.iajpr.com 
P
ag
e7
4
3
2
 
Vol 7, Issue 01, 2017.                                                       Kausar Fatima et al.                                                   ISSN NO: 2231-6876 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hence the administration of CF and EM combined formulation extract for 21 days decreased the elevated blood glucose 
levels. The above result suggests that CF and EM combined formulation at a dose of 400mg/kg.b.w was more effective than 200 
mg/kg.b.w and was almost comparable with the effect produced by standard drug glibenclamide treated group. The results were 
represented by means of graph 1 by using ANOVA followed by Dunnett’s t-test. 
 
Anti-hyperlipidemic activity:  
The lipid profiles in control and experimental rats are depicted in (Table 3) in alloxan induced diabetic rats. The diabetic 
control rats (Group II) showed significant increase in serum triglycerides, total cholesterol, very low density lipoproteins (VLDL) and 
low density lipoproteins (LDL) while decrease in High density lipoproteins (HDL) when compared with normal (Group I). The 
ethanolic extracts of Chonemorpha fragrans (CF) & Erythroxylum monogynum (EM) showed significant decrease in total cholesterol, 
LDL, VLDL, triglycerides and significant increase in HDL when compared with diabetic control group (Group II). All these effects 
were observed on day 21. Standard glibenclamide (Group V) also reduced triglycerides, total cholesterol, very low density 
lipoproteins (VLDL), low density lipoproteins (LDL) & increased High density lipoproteins (HDL) when compared with diabetic 
control rats (Group II).The present experimental result indicated that ethanolic extracts exhibited a potent serum lipid lowering 
properties in alloxan diabetic rats. 
 
Table 3: Effect of ethanolic leaf extracts of Chonemorpha fragrans and Erythroxylum monogynum on serum lipid profile in 
alloxan (150mg/kg b.w) induced diabetic rats after 21 days of treatment: 
 
Values are expressed as Mean±SEM (n=6); *P<0.05, **P<0.01, ***P<0.001 was considered significant with respect to control group 
using ANOVA followed by Dunnett’s t-test. 
 
 
 
Figure 2: Effect of ethanolic extracts of the leaves of medicinal plants on serum low density lipoprotein (ldl)(mg/dl). 
 
Groups Serum Low Density 
Lipoprotein(LDL) (mg/dl) 
Serum Very Low Density 
Lipoprotein(VLDL) (mg/dl) 
Serum High Density 
Lipoproteins (HDL)(mg/dl) 
Normal control 40.56±2.61*** 18.64±0.92*** 38.82±0.50*** 
Diabetic control 92.57 ± 2.19 37.42± 4.12 24.63± 3.24 
CF &EM treated (200 mg/kg) 45.64±0.56*** 24.35±0.42** 34.87±0.25** 
CF & EM treated (400mg/kg) 36.21±0.38*** 21.74±0.47*** 39.45 ±0.46*** 
Glibenclamide  treated 
(5mg/kg) 
35.16±0.25*** 
 
20.43±0.58*** 40.62 ±0.33*** 
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Figure 3: Effect of ethanolic extracts of the leaves of medicinal plants on serum very low density lipoprotein (Vldl)(mg/dl). 
 
 
 
Figure 4: Effect of ethanolic extracts of the leaves of medicinal plants on serum high density lipoprotein (hdl)(mg/dl). 
 
Table 4: Effect of ethanolic leaf extracts of Chonemorpha fragrans & Erythroxylum monogynum on serum total cholesterol, 
triglycerides & cholesterol ratio in alloxan (150mg/kg b.w) induced diabetic rats after 21 days of treatment: 
 
Values are expressed as Mean±SEM (n=6); *P<0.05, **P<0.01, ***P<0.001 was considered significant with respect to control group 
using ANOVA followed by Dunnett’s t-test. 
 
Groups Total cholesterol (mg/dl) Total triglycerides (mg/dl) Cholesterol ratio = tc/hdl 
Normal control 88.48±0.18*** 82.72±0.45*** 2.27±0.025 
Diabetic control 148.33± 5.89 164.47 ± 1.40 6.02±0.47 
CF & EM treated (200 mg/kg) 106.42±0.44** 115.35±0.56* 3.05±0.085** 
CF & EM treated (400 mg/kg) 91.73±0.48*** 95.46± 0.69** 2.32±0.0602** 
Glibenclamide treated (5 mg/kg) 90.24±0.48*** 96.14±0.84*** 2.22±0.105** 
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Figure 5: Effect of ethanolic extracts of the leaves of medicinal plants on total cholesterol (mg/dl). 
 
 
 
Figure 6: Effect of ethanolic extracts of the leaves of medicinal plants on serum total triglycerides (mg/dl). 
 
 
 
Figure 7: Effect of ethanolic extracts of the leaves of medicinal plants on cholesterol ratio (TC/HDL). 
 
Diabetes Mellitus is a chronic disorder caused by partial or complete insulin deficiency, which produces inadequate glucose 
control and leads to acute or chronic complications. Premature and extensive atherosclerosis involving renal, peripheral and 
cardiovascular vessels remain the major complication of diabetes mellitus. Alteration in the serum lipid profile is known to occur in 
diabetes and is likely to increase the risk of coronary heart disease. A reduction in serum lipids, particularly of LDL, VLDL fraction 
and triglycerides should be considered as been beneficial for long time prognosis. Lowering of blood glucose level and serum lipid 
level through dietary medication and drug therapy seems to be associated with the decreased risk of vascular diseases. 
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Abdominal obesity contributes to insulin resistance, a metabolic abnormality linked to the development of type 2 diabetes 
mellitus and cardiovascular disease (CVD). Insulin resistance generally precedes the development of type 2 diabetes. The 
pathophysiologic mechanisms known to increase CVD risk in individuals with insulin resistance include formation of advanced 
glycation end products (AGE’s), hypertension, proinflammatory, prothrombotic states and dyslipidemia (i.e., low levels of high-
density lipoprotein cholesterol, increased levels of triglycerides, small, dense low-density lipoprotein cholesterol particles, 
apoplipoprotein B, and inflammation). Insulin resistance and impaired glucose tolerance are associated with increased CVD risk. 
Individuals with coexisting metabolic syndrome and diabetes have the highest prevalence rates of CVD. Alloxan induces chemical 
diabetes in a wide variety of animal species by damaging the insulin secreting pancreatic β-cells resulting in the decreased endogenous 
insulin release. Reduced insulin secretion and defective insulin function results in enhanced metabolism of lipids from adipose tissue 
to the plasma. Impairment in insulin sensitivity due to high concentration of lipids in the cells is responsible for cardiovascular risk in 
diabetes mellitus. Thus altered lipid and lipoprotein pattern observed in diabetic rats could be due to defect in insulin secretion and 
action. Hypercholesterolemia and hypertriglyceridemia have been reported to occur in diabetic rats. Accumulation of cholesterol and 
phospholipids in liver is due to elevated plasma free fatty acids. 
In the present study, the combined ethanolic leaf extracts of Chonemorpha fragrans & Erythroxylum monogynum 
significantly decreased the blood glucose level in alloxan induced diabetic rats as compared with standard group which clearly 
indicates that it possess a glucose lowering effect and lipid lowering effect. It was also found to be highly effective in managing 
complications associated with diabetes mellitus such as atherosclerosis, hyperlipidemia etc. 
 
CONCLUSION 
From the present experimental findings, it is concluded that the ethanolic extracts of leaves of Chonemorpha fragrans and 
Erythroxylum monogynum exhibited promising antidiabetic and antihyperlipidemic activity in alloxan induced diabetic rats. Hence, 
Chonemorpha fragrans and Erythroxylum monogynum can be helpful in the management of diabetes mellitus, hyperlipidemia and 
other associated complications. 
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